Clinical Trial to Study the Effect of Gokshuradi Guti in patients of Madhumeha(Mild to Moderate Cases of Type 2 Diabetes Mellitus)

Clinical Study of Gokshuradi Guti in the Management of Madhumeha (Mild to Moderate Cases OF Type 2 Diabetes Mellitus) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059674

Enrollment

Registered

2023-11-08

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of both sex and age between 30 to 70 years.2. Naive patients or newly diagnosed patients of Type II Diabetes Mellitus taking oral hypoglycemic drugs for = 6 weeks.3. Patients having Glycosylated hemoglobin (HbA1c) > 6.5%.4. Patients recently diagnosed for uncomplicated NIDDM (type 2 diabetes) and having Fasting blood sugar level =126 mg/dl & =250 mg/dl & Post meal blood sugar level =200 mg/dl.5. Cases of type-2 DM not taking any other hypoglycemic drugs.6. Diabetic Patients suffering from Controlled Hypertension (Blood Pressure not more than =140 mm hg or an average Diastolic Blood Pressure not more than =90 mm hg).7. Patients willing to give informed consent and able to participate for 12 weeks.

Exclusion criteria

Exclusion criteria: 1.Patients already diagnosed and suffering from the complications of Diabetes Mellitus. 2.Patients suffering from brittle diabetes mellitus. 3.Patients who have a past history of IHD, MI, Stroke etc. within the last 6 months. 4.Patient with poorly controlled Hypertension(=160 / 100 mm Hg) 5.Patients with concurrent serious Hepatic Dysfunction, Renal Dysfunction, uncontrolled Pulmonary Dysfunction or other concurrent severe disease or Malignancy. 6.Pregnant / Lactating women. 7.Patient on steroids, oral contraceptive pills or estrogen replacement therapy. 8.Alcoholics and/or drug abusers. 9.Patients suffering from major systemic illness necessitating long term drug treatment. 10.H/o hypersensitivity to any of the trial drugs or their ingredients.

Design outcomes

Primary

Measure	Time frame
To assess the effect of Gokshuradi guti in the management of symptomatology of MadhumehaTimepoint: 45 days	—

Secondary

Measure	Time frame
To compare the effects of Gokshuradi guti with Metformin on blood glucose level parametersTimepoint: 30,45 and 90 days	—

Countries

India

Contacts

Public ContactDr Maniruddin Dewan

Govt Ayurvedic College and Hospital Ghy 14

dr.manir@gmail.com9864174788

Outcome results